Table 2 Sensitivity analysis for countries, by age group
Age group | 0–1 IRR (CI) | 1–4 IRR (CI) | 5–9 IRR (CI) | 10–14 IRR (CI) | 15–44 IRR (CI) | 45–64 IRR (CI) |
|---|---|---|---|---|---|---|
Country removed | ||||||
Australia | – | – | 1.03 (1.004–1.05) | 1.04 (0.95–1.15) | 1.11 (0.98–1.26) | 0.85 (0.77–0.94) |
Canada | 1.1 (1.01–1.2) | 1.12 (1.06–1.17) | 1.03 (1.01–1.05) | 1.07 (0.95–1.19) | 1.12 (0.98–1.28) | 0.86 (0.78–0.96) |
England | 1.11 (1.005–1.24) | 1.11 (1.03–1.2) | 0.99 (0.95–1.02) | 1.01 (0.94–1.08) | 1.08 (1.02–1.14) | 0.89 (0.77–1.03) |
Germany | 1.11 (1.01–1.22) | 1.11 (1.04–1.19) | 1.04 (1.01–1.06) | 1.07 (0.97–1.18) | 1.15 (1.03–1.28) | 0.87 (0.77–0.99) |
Israel | 1.05 (1.0002–1.1) | 1.08 (1.07–1.1) | 1.02 (1.0002–1.05) | 1.05 (0.95–1.16) | 1.12 (0.99–1.27) | 0.83 (0.77–0.88) |
New Zealand | 1.06 (0.99–1.13) | 1.1 (1.04–1.16) | 1.03 (1.003–1.05) | 1.02 (0.93–1.12) | 1.13 (1.001–1.28) | 0.83 (0.78–0.89) |
Spain | 1.1 (1.002–1.2) | 1.11 (1.05–1.17) | 1.03 (1.01–1.05) | 1.07 (0.97–1.18) | 1.13 (1.0004–1.29) | 0.85 (0.77–0.93) |